METHOD, EFFECTIVENESS, AND COMPLICATIONS OF HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATION ON HEPATOCELLULAR CARCINOMA (HCC) TREATMENT

Main Article Content

Chaowalit Monton
Worawan Saingam
Jirapornchai Suksaeree
Natawat Chankana
Tun Chusut
Lukman Sueree
Krisana Kraisintu

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. High intensity focused ultrasound (HIFU) plays an important role in treatment of HCC. HIFU has two methods in tumor treatment, which have thermal and mechanical effects. The absorption of ultrasound energy causes a rise in temperature at the target point of the tumor.  Although necrosis occurs, tissue located near the target tumor is not destroyed. Mechanical effects produce acoustic cavitations, causing tumors to be destroyed by microbubble formation.  Many clinical trials have revealed that HIFU is an effective and safe procedure for HCC ablation, both in short-term and long-term follow-up. HIFU showed a good response rate in patients suffering from HCC damage, and improved several parameters in HCC treatment. The common complications of HIFU found in many clinical trials were slight fever, localized pain, and skin burns. However, patients recovered within a few weeks after treatment as severe or major complications were minimally observed. Nevertheless, further study to support the efficacy and safety of HIFU in a larger number of cancer patients will be necessary before it can be used in treatment for other cancers. This review will investigate the use of HIFU for treatment of HCC, and will describe the method, effectiveness, and complications of HIFU.

Article Details

How to Cite
1.
Monton C, Saingam W, Suksaeree J, Chankana N, Chusut T, Sueree L, Kraisintu K. METHOD, EFFECTIVENESS, AND COMPLICATIONS OF HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATION ON HEPATOCELLULAR CARCINOMA (HCC) TREATMENT. Interprof J Health Sci [Internet]. 2023 Oct. 5 [cited 2024 Dec. 6];12(1):1-8. Available from: https://li05.tci-thaijo.org/index.php/IJHS/article/view/88
Section
Review Article

References

Al-Bataineh O, Jenne J, Huber P. 2012. Clinical and future applications of high intensity focused ultrasound in cancer. Cancer Treat. Rev. 38: 346-353.

American Cancer Society. 2011. Global Cancer Facts & Figures 2nd ed. Atlanta: American Cancer Society.

Bruix J, Sherman M. 2011. Management of hepatocellular carcinoma: An update. Hepatology. 53(3): 1020-1022.

Cheung TT, Chok KSH, Lo RCL, Sharr WW, Chan SC, Poon RTP, et al. 2012a. High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantation. Hepatobiliary Pancreat. Dis. Int. 11: 542-544.

Cheung TT, Chu FSK, Jenkins CR, Tsang DSF, Chok KSH, Chan ACY. 2012b. Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma. World J. Surg. 36: 2420-2427.

Cheung TT, Fan ST, Chan SC, Chok KSH, Chu FSK, Jenkins CR, et al. 2013. High-intensity focused ultrasound ablation: An effective bridging therapy for hepatocellular carcinoma patients. World J. Gastroenterol. 19(20): 3083-3089.

El–Serag HB. 2012. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterol. 142: 1264-1273

Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, et al. 2009. Hepatocellular carcinoma (HCC): a global perspective. (Accessed on Aug. 13, 2013, at http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/24_hepatocellular_carcinoma_en.pdf)

Foley JL, Vaezy S, Crum LA. 2007. Applications of high-intensity focused ultrasound in medicine: Spotlight on neurological applications. Appl. Acous. 68: 245-259.

Fukuda H, Numata K, Nozaki A, Morimoto M, Kondo M, Tanaka K, et al. 2012. Findings of multidetector row computed tomography of HCCs treated by HIFU ablation. Eur. J. Radiol. 81: e239-e243.

Halpern EJ. 2005. Science to practice: High-intensity focused ultrasound ablation: Will image-guided therapy replace conventional surgery? Radiology. 235(2): 345-346.

Illing RO, Kennedy JE, Wu F, ter Haar GR, Protheroe AS, Friend PJ, et al. 2005. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. British J. Cancer. 93: 890-895.

Izzo F, Cremona F, Delrio P, Leonardi E, Castello G, Pignata S, et al. 1999. Soluble interleukin-2 receptor levels in hepatocellular cancer: A more sentitive marker than alfa fetoprotein. Ann. Surg. Oncol. 6(2): 178-185.

Jang HJ, Lee JY, Lee DH, Kim WH, Hwang JH. 2010. Current and future clinical applications of high-intensity focused ultrasound (HIFU) for pancreatic cancer. Gut Liver. 4(1): S57-S61.

Jenne JW, Preusser T, Günther M. 2012. High-intensity focused ultrasound: Principles, therapy guidance, simulations and applications. Z. Med. Phys. 22: 311-322.

Jin C, Zhu H, Wang Z, Wu F, Chen W, Li K, et al. 2011. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: Long-term follow-up and clinical analysis. Eur. J. Radiol. 80: 662-669.

Jung SE, Cho SH, Jang JH, Han JY. 2010. High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: complications. Abdom. Imaging. 36: 185-195.

Leslie TA, Kennedy JE, Illing RO, Ter Haar GR, Wu F, Phillips RR, et al. 2008. High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response? British J. Radiol. 81: 564-571.

Li C, Zhang W, Zhang R, Zhang L, Wu P, Zhang F. 2010. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma. Eur. J. Cancer. 46: 2513-2521.

Li CX, Xu GL, Jiang ZY, Li JJ, Luo GY, Shan HB, et al. 2004. Analysis of clinical effect of high-intensity focused ultrasound on liver cancer. World J. Gastroenterol. 10(15): 2201-2204.

Li YY, Sha WH, Zhou YJ, Nie YQ. 2007. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma. J. Gastroenterol. Hepatol. 22: 2148-2154.

Liang Z, Wei-jun F, Jin-hua H, Chuan-xing Li, Ming Z, Li-gang W, et al. 2009. Comprehensive sequential interventional therapy for hepatocellular carcinoma. Chin. Med. J. 122(19): 2292-2298.

Liao M, Huang J, Zhang T, Wu H. 2013. Transarterial chemoembolization in combination with local therapies for hepatocellular carcinoma: A meta-analysis. PLOS ONE. 8(7): e684531.

Maruyama H, Yoshikawa M, Yokosuka O. 2008. Current role of ultrasound for the management of hepatocellular carcinoma. World J. Gastroenterol. 14(11): 1710-1719.

Numata K, Fukuda H, Ohto M, Itou R, Nozaki A, Kondou M, et al. 2010. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent. Eur. J. Radiol. 75: e67-e75.

Orsi F, Arnone P, Chen W, Zhang L. 2010a. High intensity focused ultrasound ablation: A new therapeutic option for solid tumors. J. Canc. Res. Ther. 6(4): 414-420.

Orsi F, Zhang L, Arnone P, Orgera G, Bonomo G, Vigna PD. 2010b. High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations. AJR. 195: W245-W252.

Padma S, Martinie JB, Iannitti DA. 2009. Liver tumor ablation: percutaneous and open approaches. J. Surg. Oncol. 100: 619-634.

Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, et al. 2008. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am. J. Gastroenterol. 103(4):914-921.

Shehata IA. 2012. Treatment with high intensity focused ultrasound: Secrets revealed. Eur. J. Radiol. 81: 534-541.

Wang Y, Wang W, Wang Y, Tang J. 2010. Ultrasound-guided high-intensity focused ultrasound treatment for needle-track seeding of hepatocellular carcinoma: Preliminary results. Int. J. Hyperthermia. 26(5): 441-447.

Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, et al. 2005. Advanced hepatocellular carcinoma: Treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. 235(2): 659-667.

Xu G, Luo G, He L, Li J, Shan H, Zhang R, et al. 2011. Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma. Ultrasound Med. Biol. 37(12): 1993-1999.

Yao CL, Trinh T, Wong GTC, Irwin MG. 2008. Anaesthesia for high intensity focused ultrasound (HIFU) therapy. Anaesthesia. 63: 865-872.

Zhang L, Zhu H, Jin C, Zhou K, Li K, Su H, et al. 2009. High-intensity focused ultrasound (HIFU): Effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur. Radiol. 19(2): 437-445.

Zhang Y, Zhao J, Guo D, Zhong W, Ran L. 2011. Evaluation of short-term response of high intensity focused ultrasound ablation for primary hepatic carcinoma: Utility of contrast-enhanced MRI and diffusion-weighted imaging. Eur. J. Radiol. 79: 347-352.

Zhou YF. 2011. High intensity focused ultrasound in clinical tumor ablation. World J. Clin. Oncol. 2(1): 8-27.

Zhu H, Kun Zhou A, Zhang L, Jin C, Peng S, Yang W, et al. 2009. High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: Role of partial rib resection. Eur. J. Radiol. 72: 160-166.